Prohost Portfolio PLUS #4
Celldex Therapeutics
Celldex Therapeutics (CLDX) stock is gaining momentum. On April 12, 2021 Celldex announced its presentation of promising data from its growing bispecific platform at the American Association of Cancer Research (AACR) Annual Meeting 2021 held between April 10th – 15th.
The Company described the discovery . . .
This content is for paid subscribers.
Prohost Letters
April 26, 2021
